Iron Path Capital-Backed Puretech Scientific Completes Acquisition Of Glycolic Acid Business From The Chemours Company
Iron Path Capital-Backed Puretech Scientific Completes Acquisition Of Glycolic Acid Business From The Chemours Company
08/01/23, 3:04 PM
Location
belleIndustry
biotechnology
manufacturing
PureTech Scientific LLC today announced the completion of its acquisition of the Glycolic Acid business from The Chemours Company (NYSE: CC) for $137 million in cash, making PureTech Scientific a global leader in the organic synthesis of ultra-high purity alpha hydroxy acids for the Life Sciences and Specialty Chemical industries. PureTech Scientific was founded and backed by Iron Path Capital, a private equity firm specializing in lower-middle market investments across the specialty industrial and healthcare sectors.
Company Info
Location
Belle, West Virginia, United States
Company info
PureTech Scientific, formerly Chemours Glycolic Acid Division, is the global leader in organic synthesis of ultra-high purity alpha hydroxy acids for the Life Sciences and Specialty Chemical industries, and the sole manufacturer in the Americas. With over 85 years of operating experience and a commitment to reducing our carbon footprint, we are dedicated to world-class products, innovations, and customer support for a healthier and safer world.